Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide with or without CPAP in adults with type 2 diabetes mellitus and obstructive sleep apnoea
2014-000988-41Phase 4Completed
- Sponsor
- University of Liverpool
- Start
- Aug 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of liraglutide in type 2 diabetes mellitus (T2DM) and obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by University of Liverpool. Primary endpoint: Change in apnoea-hypopnea index. Started Aug 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2014-000988-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000988-41.